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Abstract Histone acetylation is considered a major epi-
genetic process that affects brain development and synaptic
plasticity, as well as learning and memory. The transcrip-
tional effectors and morphological changes responsible for
plasticity as a result of long-term modifications to histone
acetylation are not fully understood. To this end, we
pharmacologically inhibited histone deacetylation using
Trichostatin A in adult (6-month-old) mice and found
significant increases in the levels of the acetylated histone
marks H3Lys9, H3Lys14 and H4Lys12. High-resolution
transcriptome analysis of diverse brain regions uncovered
few differences in gene expression between treated and
control animals, none of which were plasticity related.
Instead, after increased histone acetylation, we detected a
large number of novel transcriptionally active regions,
which correspond to long non-coding RNAs (lncRNAs).
We also surprisingly found no significant changes in den-
dritic spine plasticity in layers 1 and 2/3 of the visual
cortex using long-term in vivo two-photon imaging. Our
results indicate that chronic pharmacologically induced
histone acetylation can be decoupled from gene expression
and instead, may potentially exert a post-transcriptional
effect through the differential production of lncRNAs.
Keywords Histone acetylation  Epigenetics  Synaptic
plasticity  RNA-seq
Introduction
Thediscovery that reversible alterations toDNAandassociated
proteins are related to the unique patterns of gene expression
that define cell populations as well as different functional states
of the same cells (Allfrey et al. 1964; Pogo et al. 1966) initiated
research on the effects of epigenetic interactions on a variety of
cellular processes. Much of this research has suggested that
gene expression is plastic in the adult brain and that such
changes may be necessary for its function. In particular, epi-
genetic modification by histone acetylases (HATs) and
deacetylases (HDACs) appears to modulate the dynamic gene
expression which underlies synaptic plasticity (Stefanko et al.
2009; Kavalali et al. 2011) as well as learning and memory
(Haettig et al. 2011). Histone acetylation has also been con-
sidered to be critical for brain development; e.g., it has been
shown to have large effects on cell proliferation (Umka et al.
2010;Yooet al. 2011),migration (Nott et al. 2013), and synapse
formation/maturation (Akhtar et al. 2009). Indeed, there seems
to be few cellular processes which have not been assigned a
relation to histone acetylation.
Several pathways were shown to modulate the effects of
histone deacetylase inhibitors (HDACis), including theMEK/
ERK, calcium-calmodulin, and cAMP signaling pathways
(Levenson et al. 2004; Levenson and Sweatt 2006; Stefanko
et al. 2009; Haettig et al. 2011; Kavalali et al. 2011; Foti et al.
& Jamie Benoit
jamie.benoit@yale.edu; benoitj@mit.edu
Pasko Rakic
pasko.rakic@yale.edu
1 Department of Psychology, Yale University, New Haven,
CT 06520, USA
2 Department of Neurobiology, Yale University School of
Medicine, New Haven, CT 06520, USA
3 Kavli Institute for Neuroscience Yale University,
New Haven, CT 06520, USA
4 Present Address: Department of Brain and Cognitive
Sciences, Picower Institute of Learning and Memory,
Massachusetts Institute of Technology, Cambridge,
MA 02139, USA
123
Brain Struct Funct
DOI 10.1007/s00429-015-1138-0
2013). These signaling pathways are thought to be activated
by HDACi-induced changes to gene expression, which
thereby increases resilience to insult and enhances processes
dependent on plasticity pathways. Furthermore, it has been
suggested thatHDACsmayplaya role in the closure of critical
developmental periods in various brain regions, potentially
through the decoupling of ERK/MAPK signaling from
mechanisms of histone acetylation (Sweatt 2009). Indeed,
administration of HDACis has been shown to re-open the
critical period of ocular dominance plasticity after its normal
closure in the visual cortex, which suggests that a reduction in
histone acetylation could be at least in part responsible for the
switch to a mature cortex (Putignano et al. 2007). However,
the patterns of acetylation-related gene expression in indi-
vidual cell types and brain regions remain unknown.
In light of these findings, we decided to examine whe-
ther or not HDACi treatment could re-establish aspects of
critical period plasticity. To this end, we correlated changes
in gene expression and dendritic spine plasticity in the
adult visual cortex that occur during long-term HDACi
treatment and compared them to those that occur during the
critical period. Additionally, we examined changes in
specific histone acetylation residues and also in the
expression of individual gene isoforms and non-protein-
coding regions of the genome to capture a holistic view of
the transcriptional effects of increased histone acetylation.
Methods
Animals
All animals were bred and housed in a Yale animal care
facility. Male mice which provided the tissue for the RNA-seq
experiments were bred from wild-type C57BL/6 mice and
were killed at P26 or P180. Ten mice were killed in total for
RNA-Seq analysis: two at P26 and eight at P180. The two P26
animals were untreated and of the P180 mice, four were
chronically infused with TSA and four with vehicle. Age-
matched biological replicates were from different litters and
killed at different times. These mice were killed by cervical
dislocation and decapitation and the brain was quickly
extracted and flash frozen in OCT gel in a dry ice-isopentane
slurry. Once fully frozen, the brain was removed to a-80 C
freezer until dissection. Mice which were used for imaging
were Thy1-YFP mice, bred from animals generously donated
by Steven Strittmatter. These mice expressed YFP in layer 5
neurons across the cortex. Twelve of these mice were
implanted with cortical windows, comprising six vehicle-in-
fused controls and six TSA-infused mice. These mice under-
went surgery at 6 months of age and were sacrificed
immediately following imaging day 28. All procedures were
approved by the Institutional Animal Care andUseCommittee
of Yale University and conformed to the National Institutes of
Health Guide for the Care and Use of Laboratory Animals.
Pump implantation
Mini-osmotic pumps were obtained from Alzet (cat # 2002)
which were capable of infusing either TSA or vehicle con-
tinuously over the course of 2 weeks without need for
replacement. Each pump contained 200 lL of fluid, and the
concentration of Trichostatin A (TSA) diluted at a concen-
trationof10 mgTSA/mlofDMSOwas adjustedwithwater so
that the total amount of TSA in the pumpwould release a dose
equivalent to 2.5 mg/kg/day at a rate of outflow of 0.5 lL/h.
For vehicle controls, an amount of water was added to DMSO
to give the same concentration as a TSA-infused mouse of
equivalent weight. The surgical procedure consisted of
inserting the pump into a small mid-scapular incision that had
been hollowed out along the spinewith a hemostat. The pump,
therefore, rested just under the skin, along the spinal column to
prevent the animal from scratching around the pump site. For
the window-implanted animals which were required to be
infused for a full 28 days (vs 14 days of infusion for all other
experiments), the pump was replaced on day 14.
Western blotting
Micewhichwere either vehicle- or TSA-infusedwere killed by
cervical dislocation and decapitation. The occipital cortex,
frontal cortex, hippocampus, and olfactory bulb were rapidly
dissected on wet ice, immediately frozen on dry ice and stored
at-80 Cuntil use. Tissuewas homogenized by a rotary tissue
homogenizer. The homogenized samples were diluted 1:1 with
Laemmli buffer and boiled for 5 min. SDS-PAGE was then
performed using 4–20 % TGX gels (Bio-Rad, cat # 456-1093)
which were then transferred to a polyvinylidene fluoride
polymer (PVDF) membrane using a semi-dry transfer box at a
constant voltageof20 Vfor50 min.ThePVDFmembranewas
transferred to Tris-buffered saline (TBS, 0.9 % NaCl, 10 mM
Tris–HCl, pH7.5) containing 0.05 %Tween 20 (TTBS) before
being washed for 5 min in TBS and incubated for 1 h at room
temperature in TTBS containing 5 %milk. After blocking, the
membrane was washed in TTBS for 20 min. For acetylated
histones, the membrane was incubated in either a 1:1000
dilution of rabbit anti-AcH3Lys9 antibody (Sigma Aldrich, cat
# H9286), a 1:300 dilution of rabbit anti-AcH3Lys14 antibody
(Cell Signaling, cat # 4318S), or a 1:500 dilution of rabbit anti-
AcH4Lys12 antibody (Cell Signaling, cat # 2591S), in 5 %
milk TTBS overnight at 4 C on a rocker table. The following
day, after rinsing with TTBS, the blot was incubated with anti-
rabbit horseradish peroxidase-conjugated IgG (Cell Signaling)
at 1:8000 concentration in 5 % milk TTBS for 1 h at room
temperature. Bands were visualized using enhanced chemilu-
minescence (Perkin Elmer, cat # NEL104001EA) and then
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developed. Following imaging, the blot was stripped using
0.2 MNaOHand reprobedwith a 1:5000dilutionof rabbit anti-
histone H3 antibody (Millipore, cat # 05-928) or a 1:2000
dilution of rabbit anti-histone H4 antibody (Millipore cat #
362180) in 5 %milk TTBS overnight at 4 Con a rocker table.
The followingday, theblotwas incubatedwith anti-rabbit-HRP
at a 1:8000 dilution and imaged as previously. ImageJ software
was used to quantify the density of each band. Data were nor-
malized as a percentage of density relative to density of pan-
histone H3 or H4. Effects were normalized and measured
within single gels.
Laser microdissection
Whole mouse brains were mounted in a cryostat and equi-
librated at -18 C for 1 h before cutting. Sections were
made 20 lm thick and mounted on PEN slides (Leica
Microsystems). Sections were dried on the slide for 15 min
at room temperature before staining. Slides were then placed
for 30 s in 70 %EtOH, 10 s in 0.25 % toluidine blue stain in
70 % EtOH, and then 30 s each in 70–100 % EtOH. Slides
were then dried again for 5 min at room temperature before
immediate microdissection. Layers were defined based on
the morphology and density of cells. Layers 2/3 and 6 are
easily seen with toluidine staining as their cells are much
denser than neighboring layers. The upper border of layer 2/3
was defined as the edge of the dense band of cells, excluding
the acellular layer 1. Layer 6 consisted of only the cellular
layer and excluded the white matter and the subventricular
zone. Layer 4 has smaller cells than layer 2/3 and is denser
than layer 5,making it easily recognizable. As the laser cuts a
wide track into the tissue that ablates the cells within it, the
laser line was placed on the borders of the above-defined
layers and provided a buffer zone of cells that were ablated
rather than included in the samples of the layers on either
side. In thisway, the purity of the sampleswas ensured so that
they were enriched only for cells in the middle of the cor-
responding layer. Sections from one animal were used for
each biological replicate, and the two replicates in each area
came from different litters of pups which were killed at
different times.
Samples were dissected on a fully motorized LMD6000
microscope (Leica) under a 109 objective (Fig. 1); see
Table 1 fordefinitions of sample codes used in figures.
Tissue cut by the laser fell into the tops of 650 lL
microcentrifuge tubes containing 35 lL of 0.1 % b-Mer-
captoethanol in RLT buffer (Qiagen). After dissection, the
tubes were briefly centrifuged to bring all the tissue and
Fig. 1 Sampled brain regions and laser microdissection technique.
a The brain regions sampled with bulk dissections in black and
regions that were also microdissected with in blue. b In these areas,
layers were isolated by laser microdissection. All sampled tissue was
then converted to cDNA and sequenced on an Illumina HiSeq 2000
sequencer. c Expression of canonical layer markers across laser-
microdissected cortical layers. Expression level in arbitrary units with
upper and lower bounds as highest and lowest RPKM, respectively,
for the samples displayed
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buffer to the bottom of the tube, the tissue pieces disrupted
by vortexing and stored on dry ice temporarily until being
placed in a -80 C freezer until RNA extraction. Extrac-
tion was done using an RNeasy Microkit (Qiagen)
according to the manufacturer’s instructions provided for
laser-microdissected tissue. Several tubes (*4) were
combined at this stage to obtain an RNA concentration
sufficient for library preparation and sequencing ([20 ng
total RNA/sample).
RNA sequencing
The quality of the RNA samples was checked using a
BioAnalyzer (Agilent). Libraries for mRNA-Seq were
made using the standard Illumina protocol. Four samples
were multiplexed per sequencing lane and then sequenced
at 75 bp paired-end read length using an Illumina HiSeq
2000 sequencer at the Yale Center for Genomic Analysis.
Sequencing data were further processed on the Yale HPC
as previously reported (Ayoub et al. 2011). RNA seq data
have been deposited in SRA and can be found via the
bioproject profile at (http://www.ncbi.nlm.nih.gov/biopro
ject/264567).
Cortical window surgery and two-photon imaging
At 6 months of age, mice underwent surgery for implanta-
tion of a non-invasive cortical window using a previously
established protocol (Drew et al. 2010). Mice were imaged
with a Zeiss LSM510 microscope coupled to a Chameleon
Ultra II laser (Coherent Inc., Santa Clara, CA) using first a
59 objective to map the surface vasculature which is backlit
by the fluorescent dendrites underneath. This surface map
was then used to repeatedly find the same imaging sites over
multiple imaging sessions. For each animal, nine ROIs were
chosen across the occipital cortex where the window was
especially clear (Fig. 2). These were imaged every session
using a 409 objective at 29 zoom. A 100 lm z-stack was
taken at each ROI at 1 lm intervals. Imaging was performed
on 0, 4, 8 and 28 days post-surgery.
Image processing and spine turnover analysis
After the final day of imaging, the z-stack images were
processed using Zen 2009 LE (Zeiss) and dendritic spines
were analyzed. Areas of dendrite which possessed clear
spines orthogonal to the line of sight of the microscope and
Fig. 2 In vivo imaging allows tracking of dendritic spine dynamics
over several week period. a Identification of regions of interest
(ROIs). Up to nine ROIs were selected per animal in the occipital
cortex. A wide-field image was first taken with a 95 objective and
then various 940 image stacks were taken within this field of view.
These 940 images were mapped onto the 95 ‘‘roadmap’’ using the
surface vasculature as landmarks. These landmarks were then used in
subsequent imaging sessions to find and revisit the same ROIs. b–
d Examples of dendritic spine stability and instability in layers 1 and
2/3 of the occipital cortex. b Three spines (arrowheads) which were
stable over the course of the 28-day imaging period. c A spine that has
retracted by day 28 (arrow) among other stable spines (arrowheads).
d Displays a de novo spine on day 28 (arrow)
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with low to no background fluorescence were chosen for
counting. Spines were not counted which were elongated in
the z-axis as this would indicate that they could be a sec-
tion of dendrite that was oriented perpendicular to the
surface of the cortex. Spines on these defined sections were
examined across the time series and their presence or
absence was recorded. Three measures were used to char-
acterize the resulting data. Spine density was calculated as
the % of spines that were present on a section of dendrite
on a given day as a proportion of the number present on
imaging day 0. Survival fraction is the fraction of spines
recorded as present on day 0 that were still present on a
subsequent imaging day. Turnover ratio was calculated
according to the following equation:
Turnover ratio ¼ Gains þ losses
# Spines t1ð Þ þ # Spines t2ð Þ
where gains refer to the number of new spines that
appeared from t1 to t2, losses are the number of spines that
disappeared from t1 to t2 and number of spines was the total
number recorded on those imaging days. This provided an
aggregate measure of spine plasticity that was normalized
to the number of initial spines.
Statistical methods
Differential gene expression and exploratory analyses were
performed following the method by Ayoub et al. (2011)
using R. Genes with a bhp-corrected p\ 0.05 and fold
changes [±29 were considered to be differentially
expressed. Within each age, area, and condition, every
layer was compared to every other in order to identify
layer-specific genes (six comparisons each); in the adult
groups, each layer in the occipital cortex was compared to
its cognate layer in the frontal cortex and each gross brain
region was compared to every other; each layer and brain
region in the adult controls was compared to the corre-
sponding layer or region in the adult TSA condition; and
each layer the occipital cortex was compared across time
points. This yielded 30 DEG lists for the first group of
comparisons, 8 for the second, 12 for the third, and 4 for
the fourth for a total of 54 comparisons made. Using the
conservative bhp value and a fold-cutoff of[2, the number
of DEGs was relatively small for most comparisons.
RPKMs for differentially expressed gene isoforms (DEIs)
were also calculated and conditions were analyzed for
differential expression using an LRT test as for DEGs.
Novel transcriptionally active regions (nTARs) were
identified based on presence in both technical replicates, a
minimum 0.5 base-pair coverage and less than 20 base-pair
gaps with a minimum 100 base-pair length and no overlap
with known genes. nTARs were merged from replicates
and compared to each other between layers, regions and
treatment condition. Differentially expressed nTARs
(dnTARs) were merged across these same conditions and
overlap then determined with known promoters, lncRNAs
and enhancers using the Galaxy online resource (https://
usegalaxy.org/).
Functional analysis
GO annotation terms for DEGs were acquired using the
Bingo application within the open source platform Cytos-
cape (http://www.cytoscape.org/), which is used for visu-
alization and analysis of complex networks. For each
comparison of interest, Bingo listed GO terms that were
enriched in that gene set, giving the term itself as well as a
bhp-corrected p value for each. GO terms with a corrected
p value\0.05 were considered to be significantly enriched.
In addition, the functional annotation tool of the online
resource DAVID (http://david.abcc.ncifcrf.gov/) was used
for pathway analysis. For each list of DEGs, significantly
differentially expressed pathways were identified and bhp-
corrected p values generated based on the KEGG pathway
annotation. Pathways with a bhp\0.05 were considered to
be differentially expressed between the samples.
Cluster analysis
Heatmaps, unsupervised hierarchical clustering and prin-
cipal component analyses were generated in R for gene
sets. jColorGrid (http://jcolorgrid.sourceforge.net/) was
used to create other heatmaps for DEGs of interest.
Results
Systemic TSA affects histone acetylation
in the cortex
To confirm that systemic administration of TSA increases
histone acetylation in the cortex, we performed Western
blots for several acetylated histone marks, including
AcH3Lys9 and AcH3Lys14, canonical markers of tran-
scriptionally active genes (Crosio et al. 2003), and AcH4-
Lys12, a repressive histone mark that normally marks
centromeric heterochromatin (Turner et al. 1992). The
results illustrated in Fig. 3, showed a significant increase in
acetylated H3Lys9, H3Lys14 and H4Lys12 protein in the
TSA condition relative to controls in the occipital cortex,
hippocampus and olfactory bulb, with the exception of
AcH4Lys12, which was not significantly enriched in the
frontal cortex. No significant differences in condition were
found for the same samples incubated with a pan-histone
H3 or H4 antibody. Apart from this measure of histone
acetylation in the cortex, there were no other phenotypes
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(i.e., systematic weight changes or obvious behavioral
differences) which were observed over the course of TSA
administration apart from a lack of hair regrowth after
surgery. This latter effect was unsurprising given the
known anti-proliferative effects of TSA (Table 1).
High-resolution transcriptome analysis after histone
acetylation
In order to determine what genes were differentially
expressed as a result of increases in histone acetylation in
the adult cortex as well as to compare these results to
differential gene expression during development, RNA seq
was performed on samples from frontal and occipital cor-
tex in the adult (P180), divided by layer (2/3, 4, 5 and 6),
and also occipital cortex from P26 mice, similarly divided
by layer. Tissue was collected using laser capture
microdissection of six mouse brains (two adult TSA, two
adult controls and two P26 controls) (Fig. 1). Analysis of
additional regions (hippocampus and olfactory bulb) was
done by gross dissection and the results compared with
gross dissections of occipital and frontal cortex from the
same animals. This required an additional two adult ani-
mals per condition. Massive parallel sequencing was per-
formed on each sample and then reads were aligned to the
mouse genome (mm9) and their normalized abundance
calculated using the RPKM (reads per kilobase of exon
model per million mapped reads) measure, from which
composite gene models were created to get a total value for
each expressed gene. Pairwise comparisons were made
between layers, between regions, across time points and
across conditions to identify significantly differentially
expressed genes (DEGs). A likelihood ratio test was used
to calculate p values for genes between samples, using a
conservative Benjamini-Hochberg-corrected p value (bhp)
of 10-5 as the cutoff. Both biological replicates were
pooled for each pairwise analysis. Genes with a bhp\0.05
and fold changes[±29 were considered to be differen-
tially expressed. Within each age, area, and condition,
every layer was compared to every other in order to
identify layer-specific genes (six comparisons each); in the
adult groups, each layer in the occipital cortex was com-
pared to its cognate layer in the frontal cortex and each
brain region was compared to every other; each layer and
brain region in the adult controls was compared to the
corresponding layer or region in the adult TSA condition;
and each layer in the occipital cortex was compared across
time points. This yielded 30 DEG lists for the first group of
comparisons, 8 for the second, 12 for the third, and 4 for
the fourth for a total of 54 comparisons made. Using the
same bhp value and a fold-cutoff of[29, the number of
DEGs was relatively small for most comparisons (Table 2).
Some comparisons yielded as few as 12 DEGs (frontal vs
occipital whole cortex) and others as many as 1042 (control
Fig. 3 Densitometry of western blotting shows a significant increase
in acetylated H3Lys9, H3Lys14 and H4Lys12 protein in the TSA
condition relative to controls in the occipital cortex (for AcH3Lys9,
t = 2.581, df = 4, p = 0.0306; for AcH3Lys14, t = 10.99, df = 4,
p = 0.0002; for AcH4Lys12, t = 4.125, df = 4, p = 0.0072, n = 5),
frontal cortex (for AcH3Lys9, t = 2.207, df = 4, p = 0.0459; for
AcH3Lys14, t = 3.619, df = 4, p = 0.0112, n = 5), hippocampus
(for AcH3Lys9, t = 7.511, df = 4, p = 0.0017; for AcH3Lys14,
t = 4.147, df = 4, p = 0.0072; for AcH4Lys12, t = 4.077, df = 4,
p = 0.0075, n = 5) and olfactory bulb (for AcH3Lys9, t = 3.169,
df = 4, p = 0.0168; for AcH3Lys14, t = 6.337, df = 4, p = 0.0016;
for AcH4Lys12, t = 3.184, df = 4, p = 0.0167, n = 5), with the
exception of AcH4Lys12, which was not significantly enriched in the
frontal cortex (t = 1.504, df = 4, p = 0.1034, n = 5). No significant
differences in condition were found for the same samples incubated
with a pan-histone H3 or H4 antibody. Density of AcH3 and AcH4
was normalized to total H3 and H4, respectively. Mice were
administered TSA systemically at a dose of 2.5 mg/kg/day for
14 days prior to tissue collection. Asterisk indicates significance at
p\ 0.05 level
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Table 1 Definition of sample
codes as used in figures
Sample code Sample name LMD or gross
dissection
OT1L2 P180 TSA occipital cortex layer 2 sample 1 LMD
OT2L2 P180 TSA occipital cortex layer 2 sample 2 LMD
OC1L2 P180 Control occipital cortex layer 2 sample 1 LMD
OC2L2 P180 Control occipital cortex layer 2 sample 2 LMD
FC1L2 P180 TSA frontal cortex layer 2 sample 1 LMD
FC2L2 P180 TSA frontal cortex layer 2 sample 2 LMD
FT1L2 P180 Control frontal cortex layer 2 sample 1 LMD
FT2L2 P180 Control frontal cortex layer 2 sample 2 LMD
OT1L4 P180 TSA occipital cortex layer 4 sample 1 LMD
OT2L4 P180 TSA occipital cortex layer 4 sample 2 LMD
OC1L4 P180 Control occipital cortex layer 4 sample 1 LMD
OC2L4 P180 Control occipital cortex layer 4 sample 2 LMD
FT1L4 P180 TSA frontal cortex layer 4 sample 1 LMD
FT2L4 P180 TSA frontal cortex layer 4 sample 2 LMD
FC1L4 P180 Control frontal cortex layer 4 sample 1 LMD
FC2L4 P180 Control frontal cortex layer 4 sample 2 LMD
OT1L5 P180 TSA occipital cortex layer 5 sample 1 LMD
OT2L5 P180 TSA occipital cortex layer 5 sample 2 LMD
OC1L5 P180 Control occipital cortex layer 5 sample 1 LMD
OC2L5 P180 Control occipital cortex layer 5 sample 2 LMD
FT1L5 P180 TSA frontal cortex layer 5 sample 1 LMD
FT2L5 P180 TSA frontal cortex layer 5 sample 2 LMD
FC1L5 P180 Control frontal cortex layer 5 sample 1 LMD
FC2L5 P180 Control frontal cortex layer 5 sample 2 LMD
OT1L6 P180 TSA occipital cortex layer 6 sample 1 LMD
OT2L6 P180 TSA occipital cortex layer 6 sample 2 LMD
OC1L6 P180 Control occipital cortex layer 6 sample 1 LMD
OC2L6 P180 Control occipital cortex layer 6 sample 2 LMD
FT1L6 P180 TSA frontal cortex layer 6 sample 1 LMD
FT2L6 P180 TSA frontal cortex layer 6 sample 2 LMD
FC1L6 P180 Control frontal cortex layer 6 sample 1 LMD
FC2L6 P180 Control frontal cortex layer 6 sample 2 LMD
L2P26 P26 Occipital cortex layer 2 sample 1 LMD
2L2P26 P26 Occipital cortex layer 2 sample 2 LMD
L4P26 P26 Occipital cortex layer 4 sample 1 LMD
2L4P26 P26 Occipital cortex layer 4 sample 2 LMD
L5P26 P26 Occipital cortex layer 5 sample 1 LMD
2L5P26 P26 Occipital cortex layer 5 sample 2 LMD
L6P26 P26 Occipital cortex layer 6 sample 1 LMD
2L6P26 P26 Occipital cortex layer 6 sample 2 LMD
C1OB P180 Control olfactory bulb sample 1 Gross dissection
C2OB P180 Control olfactory bulb sample 2 Gross dissection
T1OB P180 TSA olfactory bulb sample 1 Gross dissection
T2OB P180 TSA olfactory bulb sample 2 Gross dissection
C1FC P180 Control frontal cortex sample 1 Gross dissection
C2FC P180 Control frontal cortex sample 2 Gross dissection
T1FC P180 TSA frontal cortex sample 1 Gross dissection
T2FC P180 TSA frontal cortex sample 2 Gross dissection
C1OC P180 Control occipital cortex sample 1 Gross dissection
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olfactory bulb vs control frontal cortex). Most comparisons
between layers of the same age and region yielded
approximately 150 DEGs (range 16–397), most compar-
isons between regions of the same age approximately
300 DEGs (range 12–1042) and most comparisons across
ages approximately 30 DEGs (range 23–47). Comparisons
between TSA-treated and control animals, however, had a
surprisingly low number of DEGs (range 5–19). As one of
our hypotheses was that TSA would induce a critical per-
iod-like pattern of gene expression in the adult cortex, the
number of genes differentially regulated between P26
occipital cortex and adult controls, between P26 and adult
TSA-treated mice, and between adult control and TSA-
treated groups was also compared (Fig. 4a). Although there
was some overlap between TSA-regulated genes and
developmentally regulated genes (P26 vs adult controls),
this was a small fraction (9/46) of the total number of
developmentally regulated genes. In addition, there were
many genes that were differentially expressed between P26
controls and TSA-treated adults, indicating the dissimilar-
ity between these groups. It is, therefore, evident that TSA
treatment does not elicit a critical period-like pattern of
gene expression. As so many comparisons were made
between replicates, we created clusters of DEGs depending
on whether they were differentially expressed across lay-
ers, regions, condition or some combination of the three.
Figure 4b shows the number and overlap of genes differ-
entially regulated by region, layer and TSA treatment.
While 1716 genes were differentially regulated by region
and 441 by layer, only 19 genes were differentially regu-
lated by TSA, and all but two overlap with layer- and/or
region-specific DEGs. Given the lack of significant TSA-
DEGs in the dataset, we then examined whether or not
there was perhaps a small but global increase in the
expression of all neuronal genes that would fall below
significance for individual genes but would be evident in a
measure of the overall level of expression. Figure 4c dis-
plays the density of genes across levels of expression (here,
log10 RPKMs). The green curves represent control samples
and the red, TSA-treated samples. The two sets of curves
overlap to a high degree, indicating that there are no global
differences in gene expression between the two conditions.
The 2-D correlation plot, principal component analysis
plot, and unsupervised hierarchical clustering heatmap
reveal that biological replicates are well correlated with
each other (Figs. 5, 6, 7, 8). They also indicate both the
quality of the data and the robustness of the negative result
for differential gene expression between TSA and control.
The expression of canonical layer markers was also ana-
lyzed (Fig. 1c) and confirmed that the microdissection
process was accurate in isolating the proper layer consis-
tently across sessions/samples as such markers were reli-
ably expressed according to their established patterns. In
addition, all of these analyses clearly show the additional
clustering of TSA-treated with control samples. In the
correlation plot, this can be seen as a high correlation
between TSA and control samples; in the PCA plot by the
proximity of these two sample types to one another; and in
the clustering heatmap, by the two groups being on the
same close branch of the dendrogram. The covariance
principal component analysis also revealed components
that corresponded well with the variables that differed
between biological replicates. In the 2-dimensional plot of
all the samples (Fig. 5a), component one clearly separates
out the grossly dissected samples from the laser-mi-
crodissected samples and component two separates the
brain regions. Figure 5b shows a three-dimensional plot of
the same data, revealing that component three accurately
distinguishes between layers. This analysis was run once
more on the microdissected samples alone (Fig. 5c). In this
plot, component 1 clearly corresponds to layer, component
2 to occipital vs frontal cortex and component 3 to age of
the animal (P26 or P180).
Functional effects of histone acetylation
In order to examine the TSA-induced DEGs by function
and expression level, we performed Gene Ontology (GO)
term and Kyoto Encyclopedia of Genes and Genomes
(KEGG) pathway analyses to characterize the nature of
TSA-upregulated and -downregulated genes. Figure 8 dis-
plays the expression levels of all genes that were differ-
entially regulated by TSA in at least one pairwise
comparison. We also performed a GO annotation analysis
Table 1 continued
Sample code Sample name LMD or gross
dissection
C2OC P180 Control occipital cortex sample 2 Gross dissection
T1OC P180 TSA occipital cortex sample 1 Gross dissection
T2OC P180 TSA occipital cortex sample 2 Gross dissection
C1HC P180 Control hippocampus sample 1 Gross dissection
C2HC P180 Control hippocampus sample 2 Gross dissection
T1HC P180 TSA hippocampus sample 1 Gross dissection
T2HC P180 TSA hippocampus sample 2 Gross dissection
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for the set of TSA-upregulated and -downregulated genes.
Only the term chemotaxis (p = 0.028) reached signifi-
cance for upregulated genes and for downregulated genes,
hemopoiesis (p = 0.044) and oxygen transport
(p = 0.028) were significant. This reveals that many of the
TSA-regulated genes were non-neuronal in origin and
likely a result of effects on non-native cells such as ery-
throcytes. A KEGG pathway analysis performed using the
Database for Annotation, Visualization and Integrated
Discovery (DAVID) online tool (http://david.abcc.ncifcrf.
gov/) on this same gene list revealed no significant dif-
ferentially regulated pathways, likely because of the pau-
city of genes in the list.
Isoforms
For most regions and layers there was little differential
isoform expression with TSA: generally on the order of
15–30 DEIs per and comparable with the number of DEGs
between control and TSA-treated groups. However, in
some cortical layers, notably layer 4, there were a larger
number of DEIs, some of which were enriched for neu-
ronal genes, in opposition to the DEG data. A GO analysis
of these isoforms revealed that although many of these
differentially spliced genes were erythrocytic or myocytic
in origin and likely a result of the effects of TSA on blood
and smooth muscle cells in the vasculature of the
microdissected tissue, some were plasticity related,
although the number was small (see Table 3). However,
given the paucity of plasticity-related genes that had dif-
ferential splicing events as a result of TSA administration
and also the limited areas where such events occurred, we
concluded that this was likely not the primary explanatory
factor behind the previously published effects of HDAC
inhibition.
Histone acetylation affects novel transcriptionally
active regions
We examined novel transcriptionally active regions
(nTARs) in an attempt to classify the effects of induced
histone acetylation on areas of the genome outside of
protein-coding regions in the adult brain. As such areas
could potentially contain enhancers, promoters and long
noncoding and micro-RNAs, differential transcription of
these regions could have a variety of effects on the cell.
Comparisons were made across layers, regions, and
experimental condition and the resulting differentially
expressed nTARs (dnTARs) were merged across these
same groupings to reveal a total of 2301 dnTARs. There
were 483 region-specific dnTARs, 806 layer-specific
dnTARs, and 1389 dnTARs across treatment condition.
There were 31 region-specific dnTARs that overlappedT
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with known enhancers (with no enhancer overlap for the
other two groups) and 65 region-specific, 47 layer-specific
and 89 TSA-dnTAR regions which overlapped with known
promoters. The number of dnTARs was clearly much
higher for the TSA group, indicating that TSA may
potentially have had an effect on the production of nTARs
outside the protein-coding region of the genome. We then
examined the number of such transcripts that overlapped
with known long noncoding RNAs (lncRNAs), as found in
the NONCODE (noncode.org) database. 343/483 (71 %) of
region-specific dnTARs, 448/806 (55.6 %) of layer-speci-
fic dnTARs, and 466/1389 (33.5 %) of TSA-regulated
dnTARs were comprised of lncRNA (Fig. 9). For TSA
dnTARs specifically, 143/649 (22 %) of TSA-upregulated
nTARs and 323/629 TSA-downregulated nTARs (51.4 %)
overlapped with lncRNA regions. This indicates that a
relative downregulation of lncRNAs took place with TSA
administration that may have had downstream effects on
transcription and translation.
Correlation of mRNA levels with ChIP-seq
for acetylated histone H3
In order to confirm that the increases in histone acetylation
seen in the Western blot experiments are indeed uncorre-
lated with any of the small gene expression changes that
were observed between conditions, we used a dataset by
Lopez-Atalaya et al. (2013) of AcH3K9 and K14 acetyla-
tion peaks that were found in the hippocampus of mice of
identical strain, which received an identical TSA dosage to
those in our study. The enrichment levels of these peaks in
the TSA group were then correlated with the expression
levels of the nearest protein-coding genes in our hip-
pocampal data. We found no significant correlation
between these two measures (R = -0.02456, p = 0.6992)
and as can be seen from the graph (Fig. 10), although
AcH3 enrichment for these peaks was approximately 2.5-
fold on average, mRNA expression was not significantly
different from the average RPKM for this dataset.
Spine turnover after chronic histone acetylation
In addition to the gene expression analysis, we attempted to
characterize the effects of TSA on downstream plasticity,
as it has been theorized that TSA can selectively modulate
the expression of plasticity-related genes (Alarcon et al.
2004; Levenson et al. 2004; Guan et al. 2009; Stefanko
et al. 2009; Barrett et al. 2011; Kavalali et al. 2011; Fass
et al. 2013). We chose to perform an in vivo imaging
experiment as it is a biologically relevant and non-invasive
method that can accurately clarify the effects of various
manipulations on plasticity in superficial cortical layers.
Thy-1 EYFP transgenic mice underwent cortical thinning
surgery at 6 months of age and were imaged over the
course of 28 days to observe rates of dendritic spine
turnover in layers 1 and 2/3 of layer 5 pyramidal neurons in
the visual cortex. High-quality volume stacks of images
were obtained for all time points (0, 4, 8, and 28 days post-
surgery) in 12 mice, with six in each condition (control vs
TSA). It was found that TSA had no effect on spine den-
sity, spine survival or spine turnover at the p = 0.05 level
(Fig. 11), indicating a lack of change in spine plasticity in
these dendrites with TSA treatment.
Fig. 4 Proportional venn diagrams and density plots of differentially
expressed genes. a Comparison of developmentally regulated genes in
the occipital cortex between P26 and P180 for both controls and TSA-
treated adults. P26 vs adult TSA has more DEGs than any other
group, indicating that TSA treatment induces a pattern of gene
expression that is highly dissimilar to that seen during later
development. b Comparison between all genes differentially regu-
lated by region, layer, TSA or any combination thereof. TSA induces
the differential expression of only two unique genes. The remaining
17 genes are jointly differentially regulated with either layer or region
or the combination of the two. This shows the lack of unique effect of
TSA on the adult brain. c Density plot of all genes across conditions.
Control sample densities are represented in green and TSA-treated
sample densities are in red. Both sets of density curves overlap to a
large extent, indicating that RPKM densities are highly similar
between the two conditions
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Discussion
The last decade has witnessed an ever-growing interest in
epigenetics and the potential role of histone acetylation and
histone deacetylases (HDACs) in regulating synaptic
plasticity by differential gene expression. Significant effort
has been invested into the potential use of HDAC inhibitors
to ameliorate neuronal dysfunction but the underlying
genetic mechanism and repercussions on specific neuronal
populations in vivo remain unclear. In the present study,
the use of a high-resolution mRNA-sequencing approach
(Ayoub et al. 2011) revealed changes in nTARs and modest
changes in isoform expression in layer 4 of the cortex but
to our surprise, negligible effects on gene expression, with
generally less than a dozen significantly differentially
expressed genes per pairwise control-Trichostatin A (TSA)
comparison, despite increased acetylation at several histone
sites. Furthermore, the paucity of plasticity-related genes
correlates with the significant stability of dendritic spines
under the same conditions. We draw from this the con-
clusion that under certain circumstances there can be large
and significant increases in histone acetylation in the brain
with no concomitant changes in gene expression or specific
types of downstream plasticity.
The only large difference between TSA and control
groups in the gene expression data was in novel tran-
scriptionally active regions (nTARs). nTARs can be asso-
ciated with known genes, but have an organization and
expression that is independent. nTARs are playing as yet
ill-defined, but clearly important roles in the cell and we,
therefore, examined their expression across treatment
conditions to determine whether TSA was affecting the cell
through expression outside of protein-coding regions.
There were many more nTARs differentially expressed
between control and TSA conditions than there were
between layers or regions, which was surprising given the
opposite results for protein-coding genes. Few of these
nTARs overlapped with known promoters and none with
known enhancer regions, but more than a third overlapped
with long noncoding RNAs [lncRNAs (Fig. 9)], which are
known to have various effects on transcription (Feng et al.
2006; Goodrich and Kugel 2006; Nagano and Fraser 2009),
splicing (Beltran et al. 2008; Brown et al. 2008) and
translation (Centonze et al. 2007; Carrieri et al. 2012).
Indeed, our data indicate that while the expression of
protein-coding genes with TSA is relatively stable,
increases in histone acetylation may modulate transcription
bFig. 5 Samples segregate by region, age and cortical layer, but not
experimental condition. a Two-dimensional plot of the two principal
components of all samples, separating regions as well as layer- from
region-dissected samples. b Three-dimensional PCA plot showing
division of cortical lamina in addition to gross brain regions as in
a. c Three-dimensional PCA plot of only layer-dissected samples
indicating that the third component of this analysis is also able to
identify P26 from adult samples. Within each adult layer, it can be
seen that the first component uncouples frontal from occipital layers,
with occipital samples being closer to the origin of the X-axis than the
frontal samples for each layer. It should be noted that although
regions, layers and age can be distinguished in these components,
there is no obvious division between TSA and control samples,
indicating their similarity
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of lncRNAs which then may have downstream effects on
the neuron in vivo.
In previous work, notable changes in gene expression
were found in cells treated with an HDAC inhibitor both in
cultured cell lines (Glaser et al. 2003; Daly and Shirazi-
Beechey 2006), and in the tissue of TSA-treated animals
(Fukuchi et al. 2009; Lopez-Atalaya et al. 2013). Until
now, however, no one to our knowledge has examined
Fig. 6 2-D correlation plot
between all sampled layers and
regions. Correlation key
indicates level of correlation
between Pearson R values of
0.85 and 1
Fig. 7 Unsupervised
hierarchical clustering heatmap
of all differentially expressed
genes. Clustering of individual
genes is shown on the left of the
heatmap and clustering of
samples above. Note close
clustering of layers and regions
and similarity between TSA-
treated and control-treated
groups
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HDACi-induced differential gene expression using next
generation sequencing. Unlike previous studies, we used a
conservative p value cut-off and more replicates, which
decrease the number of false positive genes. Another ele-
ment which perhaps may have caused these differences
between this study and the two others that examined TSA-
induced gene expression in the brain is that we used
chronic exposure rather than acute dosages, which could
have different effects on both the number and pattern of
DEGs. However, our chronic administration led to com-
parable differences in histone acetylation to those in pre-
vious acute administration experiments (Fig. 3), indicating
the lack of a causative relation between pharmacologically
induced histone acetylation events and protein-coding gene
expression under these conditions.
The question remains of why a systemic increase in
histone acetylation does not translate into significant dif-
ferences in gene transcription in neuronal tissues. In a
Fig. 8 Heatmap of all genes
differentially expressed between
TSA-administered and control
conditions between any pair of
technical replicates
Table 3 List of GO terms for TSA-induced DEIs
GO-Id Description bhp value Genes
50775 Positive regulation of dendrite
morphogenesis
1.89E-03 ACTR3|SGK1|ILK
48534 Hemopoietic or lymphoid organ
development
3.46E-03 HBA-A1|HBA-A2|PICALM|MAL|HBB-
B1|TCEA1|LRRC17|ADD2|CTNNB1
51147 Regulation of muscle cell differentiation 3.47E-03 MORF4L2|ILK|EIF5A|RCAN1
42552 Myelination 4.25E-03 PLP1|ILK|MAL|MBP
43408 Regulation of MAPKKK cascade 5.50E-03 PSAP|ILK|MAPK8IP3|MAPK9|MAL|CTNNB1
16458 Gene silencing 8.17E-03 RBM3|SIRT2|SIRT3|ADAR
48268 Clathrin coat assembly 1.12E-02 AP2B1|PICALM
6376 mRNA splice site selection 1.39E-02 CELF4|MBNL1
6412 Translation 1.96E-02 RPL19|RBM3|EIF4A2|RPL26|EIF5A|LARS2|MRPL48
48662 Negative regulation of smooth muscle cell
proliferation
2.77E-02 ILK|COMT
2762 Negative regulation of myeloid leukocyte
differentiation
3.33E-02 LRRC17|CTNNB1
34101 Erythrocyte homeostasis 3.84E-02 HBA-A1|HBA-A2|TCEA1
14910 Regulation of smooth muscle cell migration 4.24E-02 ILK|RAPGEF4
21846 Cell proliferation in forebrain 4.29E-02 FABP7|TACC2
6342 Chromatin silencing 4.56E-02 SIRT2|SIRT3
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series of ChIP seq experiments with various histone
acetylation and methylation marks, Lopez-Atalaya et al.
(2013) found that while such marks were highly correlated
with gene expression in control tissue, the de novo histone
acetylation at promoters that resulted from TSA adminis-
tration was only modestly positively correlated with
expression of their genes. Most of their DEGs were already
highly expressed and with constitutively active promoters
and intragenic regions that were already highly acetylated,
indicating that these genes were being actively transcribed
before administration of TSA. Indeed, we correlated the
same AcH3K9/14 ChIP-seq peaks found by Lopez-Atalaya
et al. (2013) with the expression of the nearest protein-
coding genes in our study, and found that there was no
concomitant increase of mRNA from these nearby genes
(Fig. 10), further indicating the disconnection between
pharmacologically induced histone acetylation and gene
expression. Our results support their conclusion that
AcH3K9/14 and H3K4Me3 were chromatin marks that
were ‘‘anchorages’’ for TSA-induced increases in tran-
scription and that such marks are permissive rather than
causative of expression. Indeed, this agrees with other work
that found a lack of effect for various histone and chro-
matin mutant variants that were missing or unable to
modify certain histone residues and yet had very little
impairment or obvious phenotype (Dai et al. 2008; Lenstra
et al. 2011). Additional evidence suggests that such chro-
matin marks may place a gene in a ‘‘poised’’ state without
active transcription (Cotney et al. 2012) or that such marks
may be the result rather than the cause of increases in
transcription. Alternatively, they may simply set-up rela-
tively permanent and stable gene expression patterns that
depend on other factors for short-term variations. It is
evident then that histone acetylation becomes somewhat
disconnected with gene expression when it is induced,
raising the question of whether this relation is correlative
rather than causative.
Fig. 9 TSA induces differential expression from non-coding
sequences. TSA induces much more differential transcription of
nTARs and comparable numbers of differentially transcribed lncRNA
to region- and layer-regulated sequences, despite a lack of difference
in expression of protein-coding genes
Fig. 10 Acetylated H3 residues in hippocampus are uncorrelated
with mRNA expression. Using a dataset by Lopez-Atalaya et al.
(2013), we correlated their ChIP-seq enrichment peaks for
AcH3K9,14 with the expression of the nearest protein-coding genes
in our hippocampal data. We found no significant correlation between
these two measures (R = -0.02456, p = 0.6992) and as can be seen
from the graph, although AcH3 enrichment was approximately 2.5-
fold, mRNA expression was not significantly different from the
average FPKM for this dataset
Fig. 11 a, b TSA had no effect on spine density or survival fraction over the 28-day experimental period. c TSA has no effect on spine turnover
as measured by turnover ratio
Brain Struct Funct
123
As mentioned previously, if the role of certain acety-
lated histone patterns is to prime a gene for expression
before some other criterion (i.e. activation of known plas-
ticity signaling pathways) is met, then the reason why
others observe a gene expression and functional effect
could be because they are performing some sort of
manipulation on the animal while it is being administered
an HDACi. To address this, the study by Lopez-Atalaya
et al. (2013) examined changes in histone acetylation pat-
terns and gene expression after an exposure to a novel
environment with and without administration of TSA.
Administration of TSA failed to affect the expression of
novelty-induced genes, indicating that if these genes are
indeed primed for expression, the presence of TSA is
insufficient to enhance it beyond the level observed in its
absence. However, neither this work nor the study by
Lopez-Atalaya et al. (2013) explicitly tested animals under
conditions known to strongly drive plasticity and so we
cannot be entirely sure whether or not we would see the
activation of plasticity-related genes or structural plasticity
in spines under such conditions.
Our analysis indicated that TSA administration
increased the levels of both activating (AcH3Lys9 and
AcH3Lys14) and repressive (AcH4Lys12) acetylation
marks (Fig. 3), which may have a balancing effect on
gene expression resulting from the opposing signal from
these two types of modifications. Indeed, TSA is a pan-
HDAC inhibitor and therefore increases histone acetyla-
tion without regard to specific residues. Perhaps a more
specific HDACi may be capable of inducing gene
expression by only inhibiting removal of activating his-
tone acetylation marks. TSA-induced histone acetylation
may instead exert its effects through production of
lncRNAs, which then modulate splicing and translation
events. Although lncRNAs do affect both histone modi-
fications (Nagano and Fraser 2009) and transcription
(Feng et al. 2006; Goodrich and Kugel 2006; Nagano and
Fraser 2009), it is unlikely that TSA is working through
such lncRNAs, as we saw little difference in the tran-
scriptional profile of protein-coding genes between con-
ditions. More likely, if these lncRNAs are exerting
functional effects, it is through differential splicing or
translation, which could have a large degree of influence
on the function of neurons without affecting gene
expression. Therefore, the possibility still exists that
HDACis are able to influence cellular processes through
the differential production of lncRNAs which then exert
post-transcriptional effects and indeed, this will likely be
a profitable area of research in the future. In any case, as
none of the differentially transcribed lncRNA had been
assigned functions at the time of publication, their roles
remain hypothetical for the time being. Although
peripheral cells such as leukocytes may have gene
expression events that are inducible by TSA administra-
tion, our data indicate that the patterns of transcription for
protein-coding regions in the mature brain are relatively
resilient to manipulation. This may not be so for
lncRNAs however. Given the necessity for stability and
constancy in the maintenance of neuronal connectivity,
memory, and function across the lifespan, it is not sur-
prising that the brain has intrinsic mechanisms to keep the
patterns of its gene expression stable in the face of out-
side influence.
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